Peer-Review Research

Nov 02, 2012
Pharmaceutical Technology
By Pharmaceutical Technology Editors
This article introduces"mean kinetic relative humidity" for evaluating the impact of humidity variability.
Oct 02, 2012
Pharmaceutical Technology
By Pharmaceutical Technology Editors
The authors examine the use of various grades of direct-compression mannitol in direct-compression tableting process to evaluate the content uniformity of micronized APIs and excipients in a solid-dosage formulation.
Oct 02, 2012
Pharmaceutical Technology
By Pharmaceutical Technology Editors
The authors describe how traditional approaches to analytical method and validation may benefit from alignment with quality-by-design concepts.
Oct 02, 2012
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Managing risk in biopharmaceutical operations is of utmost importance for patient protection.
Sep 02, 2012
Pharmaceutical Technology
By Pharmaceutical Technology Editors
The authors investigate the tablet-coating process using a combination of different simulation techniques.
Aug 02, 2012
Pharmaceutical Technology
By Pharmaceutical Technology Editors
The authors compare direct combustion with rinse and swab sampling methods.
Jun 02, 2012
Pharmaceutical Technology
By Pharmaceutical Technology Editors
The authors evaluate the thermal properties of gentamicin sulfate as a small-molecule drug model in optimizing the freeze-drying cycle.
Apr 02, 2012
Pharmaceutical Technology
By Pharmaceutical Technology Editors
In Part III of a three-part article, the authors examine various degradation routes of APIs, impurities arising from interactions in formulations, metabolite impurities, various analytical methods to measure impuritie, and ways to control impurities.
Mar 02, 2012
Pharmaceutical Technology
By Pharmaceutical Technology Editors
In Part II of a three-part article, the authors examine impurities from chiral molecules, polymorphic contaminants, and genotoxic impurities.
Feb 02, 2012
Pharmaceutical Technology
By Pharmaceutical Technology Editors
In Part I of a three-part article, the authors discuss what constitutes an impurity and the potential sources of impurities in APIs and finished drug products.
native1_300x100
lorem ipsum